Jorge R. Knorrenschild
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma.
Journal: Frontiers in endocrinology
Published: April 28, 2025
Barriers and facilitators for the utilisation of psycho-oncological services in German hospitals as perceived by patients and healthcare professionals: a mixed-methods study.
Journal: BMC health services research
Published: March 24, 2024
Difficulties of Cancer Patients' Relatives in End-of-Life Discussions: Validation of a Questionnaire.
Journal: Journal of pain and symptom management
Published: December 22, 2023
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Journal: International journal of cancer
Published: September 28, 2023
Awareness and use of psychosocial care among cancer patients and their relatives-a comparison of people with and without a migration background in Germany.
Journal: Journal of cancer research and clinical oncology
Published: March 11, 2022
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).
Journal: BMC cancer
Published: February 15, 2022
The Difficulties in End-of-Life Discussions - Family Inventory (DEOLD-FI): Development and Initial Validation of a Self-Report Questionnaire in a Sample of Terminal Cancer Patients.
Journal: Journal of pain and symptom management
Published: January 29, 2021
Collaborative advance care planning in advanced cancer patients: col-ACP -study - study protocol of a randomised controlled trial.
Journal: BMC palliative care
Published: May 20, 2020
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Journal: International journal of cancer
Published: January 22, 2020
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 11, 2018
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Journal: BMC cancer
Published: June 16, 2017
Last Updated: 09/26/2026